We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option in Cervicogenic Headache

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01687881
Recruitment Status : Completed
First Posted : September 19, 2012
Last Update Posted : December 31, 2015
Sponsor:
Collaborators:
Information provided by (Responsible Party):

Study Description
Brief Summary:

This study will highlight and validate chiropractic spinal manipulative therapy (CSMT) for cervicogenic headache (CEH). If the method proves to be effective, it will provide a new non-pharmacological treatment option for CEH. This is especially important since pharmacological management has minor effect in CEH, and alternative treatment options are warranted. The applied methodology of the study will aim towards the highest possible research standards. This international study is a collaboration between Akershus University Hospital, Innlandet Hospital and University of Oslo (UiO), Norway and Macquarie University, Australia. The multidisciplinary professional backgrounds are physiotherapy, chiropractic and medicine. By increasing the methodological quality of the investigators research to a very high level, the investigators see the method to work as a guide to increase the quality of chiropractic research in the future, as previous randomized clinical trials (RCTs) of CEH used methodology showing room for improvement.

Study hypothesis:

CSMT using the Gonstead method reduces days with CEH by at least 25% as compared to placebo (sham manipulation, i.e. broad non-specific contact, non-directional, low velocity and low amplitude) and no intervention (control group).


Condition or disease Intervention/treatment Phase
Cervicogenic Headache Other: Chiropractic Other: Sham Chiropractic Phase 3

  Show Detailed Description

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 19 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option in Cervicogenic Headache? A Randomized Controlled Clinical Trial.
Study Start Date : September 2012
Primary Completion Date : May 2014
Study Completion Date : May 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Sham Comparator: Sham Chiropractic
Sham Chiropractic manipulative therapy.
Other: Sham Chiropractic
Sham manipulation
No Intervention: Control group
No intervention: Control group.
Active Comparator: Chiropractic Spinal Manipulative Therapy
Active intervention: Chiropractic Spinal Manipulative Therapy
Other: Chiropractic
Chiropractic Spinal Manipulative Therapy


Outcome Measures

Primary Outcome Measures :
  1. Number of headache days [ Time Frame: Change from baseline to post-treatment, 3, 6, 12 months follow-up ]
    1. 25% reduction in number of headache days between active treatment and sham.
    2. 25% reduction in number of headache days between active treatment and control group.


Secondary Outcome Measures :
  1. Headache duration [ Time Frame: Change from baseline to post-treatment, 3, 6, 12 months follow-up ]
    1. 25% reduction in headache duration in hours between active treatment and sham.
    2. 25% reduction in headache duration in hours between active treatment and control group.

  2. Self reported VAS [ Time Frame: Change from baseline to post-treatment, 3, 6, 12 months follow-up ]
    1. 25% self-reported improvement on VAS between active treatment and sham.
    2. 25% self-reported improvement on VAS between active treatment and control group.

  3. Headache index [ Time Frame: Change from baseline to post-treatment, 3, 6, 12 months follow-up ]
    1. 25% reduction in headache index (frequency x duration x intensity) between active treatment and sham.
    2. 25% reduction in headache index between active treatment and control group.

  4. Headache medication [ Time Frame: Change from baseline to post-treatment, 3, 6, 12 months follow-up ]
    1. 50% reduction in headache medication between active treatment and sham.
    2. 50% reduction in headache medication between active treatment and control group.


Other Outcome Measures:
  1. Sub-analysis on x-ray findings [ Time Frame: Change formbaseline to post-treatment, 3, 6, 12 months follow-up ]
    Sub-analysis will be done on participants with structural deformities vs. normal x-ray findings.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • CEH according to at least three major criteria of the CHISG not including occipital nerve blockage
  • Age 18-70 years

Exclusion Criteria:

  • Contraindication to spinal manipulation
  • Chiropractic treatment within the last 12 months
  • Radiculopathy
  • Depression
  • Pregnancy
  • Participants whom become pregnant during the migraine trial will also be excluded from analysis from the time of pregnancy
  • Participants who change their prophylactic medical regime for headaches will be excluded in the analysis from the time of change
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01687881


Locations
Norway
Research Centre, Akershus University Hospital
Lørenskog, Norway, 1478
Sponsors and Collaborators
University Hospital, Akershus
Norwegian Foundation for Health and Rehabilitation
Norwegian Chiropractic Association
Investigators
Study Director: Michael B Russell, Professor Head and Neck research Group, Research Centre, Akershus University Hospital
More Information

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Aleksander Chaibi, PhD student, University Hospital, Akershus
ClinicalTrials.gov Identifier: NCT01687881     History of Changes
Other Study ID Numbers: CEH-K34KSF-AHUS
2829002 ( Other Identifier: Research Centre, Akershus University Hospital )
First Posted: September 19, 2012    Key Record Dates
Last Update Posted: December 31, 2015
Last Verified: December 2015

Keywords provided by Aleksander Chaibi, University Hospital, Akershus:
Chiropractic
Manipulative therapy
Cervicogenic headache

Additional relevant MeSH terms:
Headache
Post-Traumatic Headache
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Headache Disorders, Secondary
Headache Disorders
Brain Diseases
Central Nervous System Diseases